CTX001

Shares of Crispr Therapeutics AG (NASDAQ: CRSP) fell more than 7 percent Thursday morning after the U.S. Food and Drug Administration said it placed a clinical hold on the company's therapy. What Happened The FDA placed a clinical hold on the Investigational New Drug application for Crispr...